Koers HH Biotechnology Holdings Company
Aandelen
HHBT
US40423K1007
onroerend goed ontwikkeling & transacties
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0003 USD | -.--% |
|
-.--% | -.--% |
Omzet 2014 | 7,99 mln. 7,37 mln. | Omzet 2015 | 7,99 mln. 7,37 mln. | Marktkapitalisatie | 45,7 mln. 42,17 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -4 mln. -3,69 mln. | Nettowinst (verlies) 2015 | 2 mln. 1,85 mln. | EV/omzet 2014 | 2,07 x |
Nettoschuld 2014 | 12,44 mln. 11,48 mln. | Nettoliquiditeiten 2015 | 5,19 mln. 4,79 mln. | EV/omzet 2015 | 5,07 x |
K/w-verhouding 2014 |
-0,95
x | K/w-verhouding 2015 |
18,1
x | Werknemers | 121 |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 99,35% |
![Extreem 0.0003](/images/extremecours_fleche.png)
![Extreem 0.0002](/images/extremecours_fleche.png)
![Extreem 0.0002](/images/extremecours_fleche.png)
![Extreem 0.0002](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sheng Jiang
CEO | Chief Executive Officer | - | 09-09-16 |
Li Rong Wang
DFI | Director of Finance/CFO | 61 | 09-09-16 |
Liang Zou
COO | Chief Operating Officer | 44 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sheng Jiang
CEO | Chief Executive Officer | - | 09-09-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 4,22K | |
+31,82% | 26,5 mld. | |
-1,96% | 25,06 mld. | |
+14,65% | 24,69 mld. | |
-21,26% | 23,3 mld. | |
+35,56% | 20,67 mld. | |
+1,01% | 19,25 mld. | |
-1,16% | 19,05 mld. | |
+49,86% | 18,28 mld. | |
+19,98% | 14,84 mld. |